Hip resurfacing arthroplasty: Risk factors for failure over 25 years

Eric J. Yue, Miguel E. Cabanela, Gavan P. Duffy, Michael G. Heckman, Mary I. O'Connor

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Many early metal-on-polyethylene hip resurfacing arthroplasty designs were abandoned after reports of high short-term and midterm failure rates. To investigate factors associated with failure, we retrospectively reviewed our experience with early-design hip resurfacing implants in 75 patients during a 25-year period (median followup, 7.9 years; range, 0.1-25.2 years). Implant failure was defined as revision for any reason. One of 75 patients was lost to followup. The estimated rate of implant survival was 73% at 5 years, 34% at 10 years, 27% at 15 years, 12% at 20 years, and 8% at 25 years. Of the many clinical and radiographic factors considered, only age, implant type, and gender were associated with implant survival independent of other variables considered. Hip resurfacing arthroplasty showed poor overall long-term survival in this series. Particular attention should be paid to the identified risk factors as long-term followup data become available for modern designs. Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

Original languageEnglish (US)
Pages (from-to)992-999
Number of pages8
JournalClinical Orthopaedics and Related Research
Volume467
Issue number4
DOIs
StatePublished - Apr 2009

Fingerprint

Arthroplasty
Hip
Survival
Polyethylene
Survival Rate
Metals
Guidelines
Therapeutics

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Yue, E. J., Cabanela, M. E., Duffy, G. P., Heckman, M. G., & O'Connor, M. I. (2009). Hip resurfacing arthroplasty: Risk factors for failure over 25 years. Clinical Orthopaedics and Related Research, 467(4), 992-999. https://doi.org/10.1007/s11999-008-0506-y

Hip resurfacing arthroplasty : Risk factors for failure over 25 years. / Yue, Eric J.; Cabanela, Miguel E.; Duffy, Gavan P.; Heckman, Michael G.; O'Connor, Mary I.

In: Clinical Orthopaedics and Related Research, Vol. 467, No. 4, 04.2009, p. 992-999.

Research output: Contribution to journalArticle

Yue, EJ, Cabanela, ME, Duffy, GP, Heckman, MG & O'Connor, MI 2009, 'Hip resurfacing arthroplasty: Risk factors for failure over 25 years', Clinical Orthopaedics and Related Research, vol. 467, no. 4, pp. 992-999. https://doi.org/10.1007/s11999-008-0506-y
Yue, Eric J. ; Cabanela, Miguel E. ; Duffy, Gavan P. ; Heckman, Michael G. ; O'Connor, Mary I. / Hip resurfacing arthroplasty : Risk factors for failure over 25 years. In: Clinical Orthopaedics and Related Research. 2009 ; Vol. 467, No. 4. pp. 992-999.
@article{2950d91bec2e49aa804dc8feb41e7092,
title = "Hip resurfacing arthroplasty: Risk factors for failure over 25 years",
abstract = "Many early metal-on-polyethylene hip resurfacing arthroplasty designs were abandoned after reports of high short-term and midterm failure rates. To investigate factors associated with failure, we retrospectively reviewed our experience with early-design hip resurfacing implants in 75 patients during a 25-year period (median followup, 7.9 years; range, 0.1-25.2 years). Implant failure was defined as revision for any reason. One of 75 patients was lost to followup. The estimated rate of implant survival was 73{\%} at 5 years, 34{\%} at 10 years, 27{\%} at 15 years, 12{\%} at 20 years, and 8{\%} at 25 years. Of the many clinical and radiographic factors considered, only age, implant type, and gender were associated with implant survival independent of other variables considered. Hip resurfacing arthroplasty showed poor overall long-term survival in this series. Particular attention should be paid to the identified risk factors as long-term followup data become available for modern designs. Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.",
author = "Yue, {Eric J.} and Cabanela, {Miguel E.} and Duffy, {Gavan P.} and Heckman, {Michael G.} and O'Connor, {Mary I.}",
year = "2009",
month = "4",
doi = "10.1007/s11999-008-0506-y",
language = "English (US)",
volume = "467",
pages = "992--999",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Hip resurfacing arthroplasty

T2 - Risk factors for failure over 25 years

AU - Yue, Eric J.

AU - Cabanela, Miguel E.

AU - Duffy, Gavan P.

AU - Heckman, Michael G.

AU - O'Connor, Mary I.

PY - 2009/4

Y1 - 2009/4

N2 - Many early metal-on-polyethylene hip resurfacing arthroplasty designs were abandoned after reports of high short-term and midterm failure rates. To investigate factors associated with failure, we retrospectively reviewed our experience with early-design hip resurfacing implants in 75 patients during a 25-year period (median followup, 7.9 years; range, 0.1-25.2 years). Implant failure was defined as revision for any reason. One of 75 patients was lost to followup. The estimated rate of implant survival was 73% at 5 years, 34% at 10 years, 27% at 15 years, 12% at 20 years, and 8% at 25 years. Of the many clinical and radiographic factors considered, only age, implant type, and gender were associated with implant survival independent of other variables considered. Hip resurfacing arthroplasty showed poor overall long-term survival in this series. Particular attention should be paid to the identified risk factors as long-term followup data become available for modern designs. Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

AB - Many early metal-on-polyethylene hip resurfacing arthroplasty designs were abandoned after reports of high short-term and midterm failure rates. To investigate factors associated with failure, we retrospectively reviewed our experience with early-design hip resurfacing implants in 75 patients during a 25-year period (median followup, 7.9 years; range, 0.1-25.2 years). Implant failure was defined as revision for any reason. One of 75 patients was lost to followup. The estimated rate of implant survival was 73% at 5 years, 34% at 10 years, 27% at 15 years, 12% at 20 years, and 8% at 25 years. Of the many clinical and radiographic factors considered, only age, implant type, and gender were associated with implant survival independent of other variables considered. Hip resurfacing arthroplasty showed poor overall long-term survival in this series. Particular attention should be paid to the identified risk factors as long-term followup data become available for modern designs. Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.

UR - http://www.scopus.com/inward/record.url?scp=62449148297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62449148297&partnerID=8YFLogxK

U2 - 10.1007/s11999-008-0506-y

DO - 10.1007/s11999-008-0506-y

M3 - Article

C2 - 18813892

AN - SCOPUS:62449148297

VL - 467

SP - 992

EP - 999

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 4

ER -